Literature DB >> 29530410

High-mobility group box 1 protein (HMGB1) operates as an alarmin outside as well as inside cells.

Ulf Andersson1, Huan Yang2, Helena Harris3.   

Abstract

Alarmins are preformed, endogenous molecules that can be promptly released to signal cell or tissue stress or damage. The ubiquitous nuclear molecule high-mobility group box 1 protein (HMGB1) is a prototypical alarmin activating innate immunity. HMGB1 serves a dual alarmin function. The protein can be emitted to alert adjacent cells about endangered homeostasis of the HMGB1-releasing cell. In addition to this expected path of an alarmin, extracellular HMGB1 can be internalized via RAGE-receptor mediated endocytosis to the endolysosomal compartment while attached to other extracellular proinflammatory molecules. The endocytosed HMGB1 may subsequently destabilize lysosomal membranes. The HMGB1-bound partner molecules depend on the HMGB1-mediated transport and the induced lysosomal leakage to obtain access to endosomal and cytosolic reciprocal sensors to communicate extracellular threat and to initiate the proper activation pathways.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Alarmins; DAMPs; HMGB1; Inflammation; RAGE; Sepsis; TLR4; Trauma

Mesh:

Substances:

Year:  2018        PMID: 29530410     DOI: 10.1016/j.smim.2018.02.011

Source DB:  PubMed          Journal:  Semin Immunol        ISSN: 1044-5323            Impact factor:   11.130


  89 in total

Review 1.  Location is the key to function: HMGB1 in sepsis and trauma-induced inflammation.

Authors:  Meihong Deng; Melanie J Scott; Jie Fan; Timothy R Billiar
Journal:  J Leukoc Biol       Date:  2019-04-04       Impact factor: 4.962

Review 2.  Interactions of high mobility group box protein 1 (HMGB1) with nucleic acids: Implications in DNA repair and immune responses.

Authors:  Pooja Mandke; Karen M Vasquez
Journal:  DNA Repair (Amst)       Date:  2019-09-16

3.  Melatonin Ameliorates Lipopolysaccharide-Induced Microglial Inflammation via Triggering SIRT1/HMGB1 Signaling Axis.

Authors:  Enkhmurun Chibaatar; Kai Le; Idriss Ali Abdoulaye; Shanshan Wu; Yijing Guo
Journal:  J Mol Neurosci       Date:  2020-09-10       Impact factor: 3.444

Review 4.  Molecular insights into the therapeutic promise of targeting HMGB1 in depression.

Authors:  Tarapati Rana; Tapan Behl; Vineet Mehta; Md Sahab Uddin; Simona Bungau
Journal:  Pharmacol Rep       Date:  2020-10-04       Impact factor: 3.024

5.  Immunohistochemical Staining of TLR4 in Human Skeletal Muscle Samples.

Authors:  Daniela Verzola; Samantha Milanesi; Francesca Costigliolo; Giacomo Garibotto
Journal:  Bio Protoc       Date:  2019-01-20

Review 6.  Damage-Associated Molecular Patterns As Double-Edged Swords in Sepsis.

Authors:  Mian Zhou; Monowar Aziz; Ping Wang
Journal:  Antioxid Redox Signal       Date:  2021-03-30       Impact factor: 8.401

7.  Conformation and protein interactions of intramolecular DNA and phosphorothioate four-way junctions.

Authors:  Maria Troisi; Mitchell Klein; Andrew C Smith; Gaston Moorhead; Yonatan Kebede; Raymond Huang; Elliott Parker; Hector Herrada; Elizabeth Wade; Samara Smith; Payson Broome; Jonah Halsell; Louis Estevez; Anthony J Bell
Journal:  Exp Biol Med (Maywood)       Date:  2020-12-20

8.  Class IIa HDAC Downregulation Contributes to Surgery-Induced Cognitive Impairment Through HMGB1-Mediated Inflammatory Response in the Hippocampi of Aged Mice.

Authors:  Chen-Miao Huang; Jia-Jing Cai; Shao-Wu Jin; Qi-Cheng Lin; Qian-Juan Fang; Ke Nan; Yuan Han; Wen-Wei Ge; Yu Liu; Yuan-Xiang Tao; Hong Cao; Jun Li
Journal:  J Inflamm Res       Date:  2021-05-31

9.  Therapeutic administration of etoposide coincides with reduced systemic HMGB1 levels in macrophage activation syndrome.

Authors:  Karin Palmblad; Hanna Schierbeck; Erik Sundberg; Anna-Carin Horne; Helena Erlandsson Harris; Jan-Inge Henter; Ulf Andersson
Journal:  Mol Med       Date:  2021-05-11       Impact factor: 6.354

10.  Increased cell-free fetal DNA release after apoptosis and sterile inflammation in human trophoblast cells.

Authors:  Nazanin Yeganeh Kazemi; Bohdana Fedyshyn; Isabel Yelsa; Yaroslav Fedyshyn; Rodrigo Ruano; Svetomir N Markovic; Rana Chakraborty; Elizabeth Ann L Enninga
Journal:  Am J Reprod Immunol       Date:  2021-07-20       Impact factor: 3.886

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.